Individual structural MRI abnormality indexes are associated with molecular, histological and cognitive indicators for frontal glioma patients
Preprint in Research Square (March 2021)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide
Article in Cochrane Database of Systematic Reviews (March 2021)
Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma
Article in Journal of Neuro-Oncology (November 2020)